swelling and rupture of mitochondria and a reduction in ATP/ADP ratio compared with untreated cells. These effects of concanavalin A were markedly reduced by oc-methyl-Dmannopyranoside, indicating that the concanavalin A binding sites on the LAT cells are sterically related to this sugar. The observed effects on the mitochondria may provide an explanation for the known cytotoxic effect of concanavalin A on ascites tumour cells. Chlorambucil has been used extensively for the treatment of chronic lymphoblastic leukaemia but the development of resistance to the drug has restricted its usefulness. An understanding of its mode of action when used in combination with other substances may lead to a wider application of the drug in cancer therapy. In recent years vitamin A and caffeine have been reported to enhance the anti-tumour effect of certain alkylating agents (Cohen and Carbone, J. natn. Cancer Inst., 1972, 48, 921; Cohen, J. natn. Cancer Inst., 1972, 48, 927) .
ACCENTUATION OF CHLORAM-
In view of these observations, we have investigated the combined effect of chlorambucil, vitamin A, caffeine and phenobarbitone on an established tumour cell line derived from a male rat breast. The viable cell counts in chlorambucil (Chl), Chl + phenobarbitone (Pb), Chl + Pb + caffeine (Caf) and Chl + Pb + Caf + vitamin A were 610%, 4400, 40% and 25% of the control counts respectively after 3 days, at which time these combinations had their greatest efficacy. In recent years it has been possible to obtain growth of human tumours in " immune deprived " rodents. We have observed that certain types of tumour, for example, carcinoma of the colon and rectum, almost invariably become established and others have proved difficult to grow. During this work a number of factors have emerged that seem likely to influence the establishment of human tumour grafts. These factors include species of recipient, method of immune deprivation, blood levels of sex hormones in the recipient and size and site of implant. Phenothiazines cause a rise in plasma prolactin in normal subjects when given orally or by injection (Frantz et al. and Bryant and Greenwood, 1972 . Ciba Symposium Lactogenic Hormones. Ed. G. B. W.
CHLORPROMAZINE STIMULATION OF PROLACTIN
Wolstenholme and J. Knight. London and Edinburgh: Churchill Livingstone). Turkington (J. clin. Endocr. 1972, 34, 247) described the acute stimulation of prolactin secretion using 50 mg of chlorpromazine i.m. The prolactin response was diminished in hypopituitarism.
Six patients with breast cancer were similarly tested. The plasma prolactin response was measured by homologous radioimmunoassay. The mean basal plasma prolactin was 13-7 + (s.e.) 7-5 mAmp/ml. This rose to a peak of 77-3 ± 11-4 mAmp/ml within 2 hours of the injection.
One to three months after yttrium implant pituitary ablation for advanced breast cancer, patients received a similar stimulation of residual prolactin cell function. This was in addition to the standard test of growth hormone response to insulin reduced hypoglycaemia (Stewart et al., J. Endocr., 1971, 50, 41 
